IL6 and type 2 diabetes mellitus: T2DM and NAFLD leads to the increased release of free fatty acids from adipocytes and the release of multiple pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), leptin, and resistin; and decreased secretion of adiponectin.